Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
34,967,317
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
18,975,246
-
Shares change
-
+386,049
-
Total reported value, excl. options
-
$183,295,913
-
Value change
-
+$4,233,889
-
Number of buys
-
28
-
Number of sells
-
-28
-
Price
-
$9.66
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2021
70 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q1 2021.
Apyx Medical Corp - Common Stock (APYX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,975,246 shares
of 34,967,317 outstanding shares and own 54.27% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3,391,279 shares), Archon Capital Management LLC (2,449,402 shares), BlackRock Inc. (2,424,411 shares), VANGUARD GROUP INC (1,471,404 shares), PURA VIDA INVESTMENTS, LLC (958,488 shares), JPMORGAN CHASE & CO (816,622 shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615,000 shares), Taylor Frigon Capital Management LLC (611,712 shares), ROYCE & ASSOCIATES LP (558,800 shares), and COWEN AND COMPANY, LLC (522,042 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.